Genotypic and Phenotypic Assessment of Hyaluronidase among Type Strains of a Select Group of Staphylococcal Species by Hart, Mark E. et al.
Hindawi Publishing Corporation
International Journal of Microbiology
Volume 2009, Article ID 614371, 8 pages
doi:10.1155/2009/614371
Research Article
Genotypicand PhenotypicAssessmentof Hyaluronidase among
TypeStrains of a SelectGroupof StaphylococcalSpecies
Mark E. Hart,1,2 Morgan J. Hart,3 andAnnaJ. Roop3
1Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jeﬀerson,
AR 72079, USA
2Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
3Department of Biology, Ouachita Baptist University, Arkadelphia, AR 71998, USA
Correspondence should be addressed to Mark E. Hart, mark.hart@fda.hhs.gov
Received 13 August 2009; Accepted 15 October 2009
Recommended by William M. Shafer
Hyaluronidasesdegradehyaluronicacid,amajorpolysaccharideoftheextracellularmatrixoftissues,andareconsideredimportant
for virulence in a number of Gram-positive and -negative bacteria. The purpose of the present study was to determine the
prevalence of hyaluronidase among clinical strains of Staphylococcus aureus and among other Staphylococcus species. Spent media
and chromosomal DNA were assessed for hyaluronidase activity and the absence or presence of a hyaluronidase gene (hysA)b y
Southern analysis, respectively. All S. aureus strains examined exhibited at least one hybridizing band (half of the strains exhibited
two or more hybridizing bands) when probed for hysA and all but three of these strains produced hyaluronidase. In contrast,
none of the type strains of 19 other species exhibited either hyaluronidase activity or hybridizing bands when probed for hysA.
These data support the hypothesis that among members of the Staphylococcus genus only strains of S. aureus possess the enzyme
hyaluronidase. This would suggest that hyaluronidase represents yet another potential virulence factor employed by S. aureus to
cause disease and may represent a diagnostically important characteristic for distinguishing S. aureus from other members of this
genus.
Copyright © 2009 Mark E. Hart et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Hyaluronidase, an enzyme that primarily degrades hyalu-
ronic acid, a major component of the extracellular matrix of
h u m a nt i s s u e s ,h a sb e e nf o u n di nb o t hG r a m - p o s i t i v ea n d
-negative bacteria and, in several cases, has been implicated
in the disease process as a means to either invade tissues
or generate a source of carbon and energy [1–8]. A role
for hyaluronidase in S. aureus diseases has been suggested
by Makris et al. [9], who demonstrated, using a mouse
abscess model, that the number of viable cells recovered
for a hyaluronidase mutant strain was signiﬁcantly less than
that for its parent strain. Recent proteomic studies of spent
mediafromStaphylococcusaureusUAMS-1anditsregulatory
mutants, sarA, agr,a n dsarA agr,d e t e c t e dt w od i ﬀerent
proteins identiﬁed as hyaluronidases [10]. Concentrations of
these proteins were higher in the sarA and sarA agr mutant
strains than in the parent and agr mutant strains, suggesting
the involvement of SarA, an important regulator of virulence
in S. aureus, in the regulation of hyaluronidase [10]. While
the exact role of hyaluronidase in S. aureus is not known, the
involvement of sarA in the regulation of the hyaluronidase
gene (hysA) expression [9, 10] and the identiﬁcation of
genes annotated as putative hyaluronidases in all fourteen
sequenced strains of S. aureus [11] would indicate that S.
aureushyaluronidaseisavirulencefactorimportantforsome
aspect of disease.
The genus Staphylococcus is a diverse group of some
41 known species [12, 13]. In the human clinical setting
the production of coagulase is usually used to distinguish
between S. aureus and all other species, which are typically
grouped together as the coagulase-negative staphylococci
(CoNS) [14]. However, species other than S. aureus produce
coagulase even though their encounter in the human clinical2 International Journal of Microbiology
setting is rare [14–18]. These species are S. intermedius, S.
delphini, S. schleiferi subsp. coagulans, S. hyicus subsp.h yi c u s ,
and S. lutrae [13, 19–22].
The presence or absence of hyaluronidase among the
staphylococci has been examined, previously. For example,
Choudhuri and Chakrabarty [23] examined 523 staphylo-
coccal isolates from human pathologies, and of the 96%
that were coagulase positive, only 13% were negative for
hyaluronidase activity. Nine of the remaining 21 strains
that were coagulase-negative were shown not to produce
hyaluronidase [23] .E s s e r sa n dR a d e b o l d[ 24] examined
368 staphylococcal strains isolated from human specimens,
and of the 218 determined to be coagulase positive, only
one isolate was hyaluronidase negative. Of the remaining
150 strains determined to be coagulase negative, only one
isolate had hyaluronidase activity [24]. An additional 495
strains were examined for their ability to produce DNAse
and hyaluronidase [24]. Only ten of the 323 DNAse positive
strains were negative for hyaluronidase activity while 170
of the remaining 172 strains designated DNAse negative
were also negative for hyaluronidase activity. Collectively,
these data [23, 24] indicate that hyaluronidase activity is
predominantly seen among strains of staphylococci that
exhibit both coagulase and DNAse activity, two charac-
teristics typically used to distinguish S. aureus from other
staphylococcal species, at least in the context of human
disease [13]. While it appears that hyaluronidase activity
is found among nearly all strains of S. aureus, S. hyicus
subsp. hyicus, a strain known to cause infectious exudative
epidermititis in swine, has also been reported positive for
hyaluronidase activity [13, 19, 25]. To the best of our
knowledge, hyaluronidase activity among other species of
Staphylococcus has not been systematically examined. The
purpose ofthepresentstudywastodetermine theprevalence
of hyaluronidase in members of the genus Staphylococcus,
primarily those associated with human disease.
2.MaterialsandMethods
2.1. Staphylococcal Strains and Growth Conditions. S. aureus
strains used in this study are listed in Table 1. While
these strains were obtained primarily from two sources,
the University of Arkansas for Medical Sciences and the
University of Nebraska Medical Center, the strains represent
a diverse group of clinical isolates originally obtained
from diﬀerent geographical locations, outbreaks, and disease
syndromes.OtherspeciesexaminedwereS.auricularisATCC
33753T, S. capitis subsp. capitis ATCC 27840T, S. caprae
ATCC 35538T, S. carnosus subsp. carnosus ATCC 51365T,
S. chromogenes ATCC 43764T, S. cohnii subsp. cohnii ATCC
29974T, S. delphini ATCC 49171T, S. epidermidis ATCC
14990T, S. epidermidis ATCC 12228, S. haemolyticus ATCC
29970T, S. hominis subsp. hominis ATCC 27844T, S. hyicus
subsp. hyicus ATCC 11249T, S. intermedius ATCC 29663T,
S. lugdunensis ATCC 43809T, S. saprophyticus ATCC 19701T,
S. schleiferi subsp. coagulans ATCC 49549T, S. schleiferi
subsp. schleiferi ATCC 43808T, S. sciuri subsp. sciuri ATCC
29062T, S. simulans ATCC 27848T, S. warneri ATCC 27836T,
and S. xylosus ATCC 29971T. Strains were maintained as
frozen (−80
◦C) stocks in brain heart infusion broth (BHI;
Difco Laboratories, Detroit, Mich.) containing 25% (w/v)
glycerol and routinely streaked for isolation on tryptic soy
broth(TSB;Difco)containingagar(1.5%).Flaskscontaining
20mL of TSB were inoculated from plate cultures and
incubated at 37
◦C overnight (15–18 hours) with rotary
(180rpm) aeration.
2.2. DNA Isolation and Southern Analysis. Chromosomal
DNA was isolated using the GenElute Bacterial Genomic
DNA Kit (Sigma-Aldrich Chemical Co., St. Louis, Mo)
and digested with ClaI restriction endonuclease, resolved
by agarose gel electrophoresis, and transferred to neu-
tral nylon membranes (MagnaGraph; Micron Separations
Inc., Westborough, Mass.) by passive diﬀusion. Mem-
branes were hybridized overnight with a digoxigenin-labeled
(Roche Molecular Biochemicals, Indianapolis, Ind.) ampli-
con generated by PCR using either S. aureus UAMS-1 or
RN6390 (8325 lineage) chromosomal DNA as template and
primers (5 -GTGGATTGTTTGACAGTAGACAG-3  and 5 -
CGGTATTTGTAGATTCGGGATTATAG-3 ) designed from
the known genomic sequence of S. aureus N315 [26]. The
amplicons were cloned and their identities were veriﬁed
by sequencing. Each amplicon (probe) was 2,442bp in size
beginning 116 bases upstream of the start codon and ending
approximately 100 bases short of the end of the gene.
Hybridization was carried out at 65
◦C and hybridizing
bands were detected by autoradiography using alkaline
phosphatase-conjugated antidigoxigenin F(ab
 )2 antibody
fragments(RocheMolecularBiochemicals)andthechemilu-
minescent substrate CDP-Star (Roche Molecular Biochemi-
cals).
2.3. Concentration of Spent Media. Optical density readings
of overnight cultures (15–18 hours) were determined spec-
trophotometrically at 550nm and used to dilute each culture
with TSB to an optical density of 3.0 in a total volume of
10mL. Diluted cultures were centrifuged (10,000 ×g,f o r1 0
minutes at 4◦C) and spent media were ﬁlter sterilized before
concentration using ultraﬁltration (Centricon Ultracel YM-
3 ﬁlters with 3,000 MWCO, Millipore Corporation, Bedford,
Maine)andaone-hourcentrifugation(7,500×g)at4 ◦C.The
retentates were recovered and stored at −80
◦C until needed.
2.4. Plate Assay for Detecting Hyaluronidase in Spent Media.
Sterile plastic square plates containing 1% (w/v) SeaKem
LE agarose (Cambrex BioScience Rockland, Inc., Rockland,
Maine), 1% (w/v) bovine serum albumin (BSA; Fraction
V; Fisher Scientiﬁc, Fair Lawn, NJ), and 0.4mgmL
−1 of
hyaluronic acid (HA; Sigma, H-1504; potassium salt, from
human umbilical cord) in 0.3M sodium phosphate buﬀer
(pH 5.3) were prepared according to Steiner and Cruce [27].
OncetheagarosemediumcontainingBSAandHAhadsolid-
iﬁed, 4mm wells were made aseptically, and 20μLo fs p e n t
media was pipetted into each well. Plates were incubated
overnight (15–18 hours) at 37
◦C prior to ﬂooding each plate
with 2M acetic acid. Clear zones were visualized againstInternational Journal of Microbiology 3
Table 1: Hyaluronidase activity of Staphylococcus aureus strains.
Strain Relevant description Source HA activity∗ hysA#
NCH 265 ATCC 29213 ATCC§ 13.2 ± 1.3 1
NCH 340 ATCC 12600T ATCC 9.7 ± 0.6 1
NTH 125 ATCC 25923 ATCC 8.7 ± 0.8 2
NCH 49 MN8 (vaginal TSS¶)N A R S A † 8.7 ± 0.3 2
NCH 47 Mu50 (HA-MRSA) NARSA 9.2 ± 0.3 1
NCH 51 MW2 (CA-MRSA) NARSA 9.5 ± 0.5 1
NCH 48 N315 (HA-MRSA) NARSA 7.0 ± 0.5 1
NCH 328 Newman T. Foster, Trinity College, Dublin, Ireland 5.8 ± 2.5 1
NCH 331 Newman (sigB) T. Foster, Trinity College, Dublin, Ireland 10.0 ± 01
NCH 88 Sanger-252 (EMRSA-16) NARSA 7.2 ± 2.0 2
NCH 78 SH1000 (RN6390, rsb+) S .F o s t e r ,U n i v .S h e ﬃeld, Sheﬃeld, England 11.3 ± 0.6 1
NCH 79 SH1000 (RN6390, rsb) S .F o s t e r ,U n i v .S h e ﬃeld, Sheﬃeld, England 12.5 ± 3.0 1
NTH 13 UAMS-1 M.S. Smeltzer, UAMS
¦ 9.0 ± 1.3 2
NCH 310 USA300 (Miss.) M.S. Smeltzer, UAMS 9.8 ± 0.3 1
NCH 338 USA300 (LAC) A.R. Horswill, University of Iowa 10.2 ± 1.6 1
NCH 239 Vaginal TSS P.D. Fey, UNMC! 6.8 ± 0.6 2
NCH 240 Vaginal TSS P.D. Fey, UNMC 8.8 ± 1.8 1
NCH 241 Vaginal TSS P.D. Fey, UNMC 0 ± 02
NCH 242 Vaginal TSS P.D. Fey, UNMC 0 ± 01
NCH 243 Vaginal TSS P.D. Fey, UNMC 8.5 ± 0.7 2
NCH 244 Vaginal TSS P.D. Fey, UNMC 10.0 ± 0.5 1
NCH 245 Vaginal TSS P.D. Fey, UNMC 9.7 ± 0.6 2
NCH 246 Vaginal TSS P.D. Fey, UNMC 7.8 ± 0.8 2
NCH 247 Vaginal TSS P.D. Fey, UNMC 6.7 ± 1.2 1
NCH 248 Vaginal TSS P.D. Fey, UNMC 8.0 ± 1.7 2
NCH 249 Vaginal TSS P.D. Fey, UNMC 8.0 ± 0.9 2
NCH 250 Vaginal TSS P.D. Fey, UNMC 0 ± 02
NCH 251 Vaginal TSS P.D. Fey, UNMC 8.3 ± 1.0 2
NCH 252 Vaginal TSS P.D. Fey, UNMC 7.3 ± 0.8 2
NCH 253 Vaginal TSS P.D. Fey, UNMC 6.8 ± 1.0 2
NCH 254 Vaginal TSS P.D. Fey, UNMC 8.2 ± 0.8 2
NTH 68 UAMS-625 (Abscess) M.S. Smeltzer, UAMS 11.0 ± 3.0 1
NTH 69 UAMS-632 (Wound) M.S. Smeltzer, UAMS 6.2 ± 1.0 2
NTH 70 UAMS-635 (Blood) M.S. Smeltzer, UAMS 13.5 ± 1.3 1
NTH 71 UAMS-636 (Wound) M.S. Smeltzer, UAMS 13.0 ± 01
NTH 72 UAMS-639 (Tracheal) M.S. Smeltzer, UAMS 8.7 ± 0.8 2
NTH 73 UAMS-640 (Abscess) M.S. Smeltzer, UAMS 10.3 ± 0.6 2
NTH 74 UAMS-641 (Blood) M.S. Smeltzer, UAMS 7.2 ± 1.0 2
NTH 75 UAMS-655 (Blood) M.S. Smeltzer, UAMS 13.2 ± 0.8 2
NTH 76 UAMS-682 (Outbreak 2) M.S. Smeltzer, UAMS 12.0 ± 1.0 2
NTH 77 UAMS-687 M.S. Smeltzer, UAMS 9.0 ± 0.5 1
NTH 78 UAMS-688 M.S. Smeltzer, UAMS 11.8 ± 0.8 2
NTH 79 UAMS-689 M.S. Smeltzer, UAMS 10.8 ± 0.8 3
NTH 80 UAMS-690 (Outbreak 1) M.S. Smeltzer, UAMS 0.5 ± 0.6 1
NTH 81 UAMS-691 (Outbreak 2) M.S. Smeltzer, UAMS 12.8 ± 1.0 3
NTH 82 UAMS-697 M.S. Smeltzer, UAMS 14.0 ± 0.5 1
∗Values represent the mean diameter in millimeters ± the standard deviation of three independent determinations.
#Values represent the number of chemiluminescent bands detected when hybridized with a hysA speciﬁc probe.
§American Type Culture Collection (ATCC), Manassas, Va.
TType strain
¶Toxic shock syndrome.
†Network for Antimicrobial Resistant Staphylococcus aureus.
¦University of Arkansas for Medical Sciences, Little Rock, Ark.
!University of Nebraska Medical Center, Omaha, Neb.4 International Journal of Microbiology
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Figure 1: Southern analysis of chromosomal DNA from Staphylo-
coccus species hybridized with a probe speciﬁc for hysA.P a n e l( a )
S. aureus NCH 239 (1), NCH 240 (2), NCH 241 (3), NCH 242
(4), NCH 243 (5), NCH 244 (6), NCH 245 (7), NCH 246 (8), S.
auricularis ATCC 33753T (9), S. capitis subsp. capitis ATCC 27840T
(10), S. caprae ATCC 35538T (11), S. carnosus subsp. carnosus ATCC
51365T (12), S. chromogenes ATCC 43764T (13), S. cohnii subsp.
cohnii ATCC 29974T (14), S. delphini ATCC 49171T (15), S. hominis
subsp. hominis ATCC 27844T (16), S. aureus NCH 78 (17), and
NCH 88 (18). Panel (b) S. aureus NTH 74 (1), NTH 75 (2), NTH
76 (3), NTH 77 (4), NTH 78 (5), NTH 79 (6), NTH 80 (7), NTH 81
(8), S. intermedius ATCC 29663T (9), S. lugdunensis ATCC 43809T
(10),S.saprophyticusATCC19701T (11),S.schleiferisubsp.schleiferi
ATCC 43808T (12), S. epidermidis ATCC 12228 (13), S. aureus NTH
125 (14), NCH 265 (15), S. intermedius ATCC 29633T (16), NCH
78 (17), and NCH 88 (18). Panel (c) S. aureus NCH 47 (1), NCH 48
(2), NCH 49 (3), NCH 51 (4), S. sciuri subsp. sciuri ATCC 29062T
(5), S. simulans ATCC 27848T (6), S. warneri ATCC 27836T (7), S.
xylosusATCC29971T (8),S.aureusNTH13(9),NCH78(10),NCH
79 (11), NTH 82 (12), NCH 88 (13), S. haemolyticus ATCC 29970T
(14), NCH 328 (15), NCH 331 (16), NCH 78 (17), and NCH 88
(18). M: marker (kilobases).
a background of opaque precipitated BSA conjugated to
undigested HA and their diameters measured in millimeters.
Puriﬁed bovine testicular hyaluronidase (Sigma, H-3506)
was used as a positive control.
2 . 5 .P l a t eA s s a yf o rD e t e c t i n gH y a l u r o n i d a s e - P r o d u c i n g
Colonies in Mixed Culture. Tryptic soy broth (6g in 120mL
of water) containing 1% (w/v) agarose was sterilized by
autoclaving. The molten medium was equilibrated to 50
◦C
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Figure 2: Southern analysis of chromosomal DNA from Staphylo-
coccus species hybridized with a probe speciﬁc for hysA.P a n e l( a )
S. aureus NCH 247 (1), NCH 248 (2), NCH 249 (3), NCH 250 (4),
NCH 251 (5), NCH 252 (6), NCH 253 (7), NCH 254 (8), NCH 78
(9), and NCH 88 (10). Panel (b) S. aureus NCH 310 (1), NCH 338
(2), NCH 340 (3), S. epidermidis ATCC 14990T (4), S. aureus NTH
68 (5), NTH 69 (6), NTH 70 (7), NTH 71 (8), NTH 72 (9), NTH 73
(10), NCH 78 (11), and NCH 88 (12). M: marker (kilobases).
prior to the addition of 40mL of ﬁlter-sterilized BSA (5%
[w/v] prepared in water) and 40mL of ﬁlter-sterilized HA
(1mgmL
−1 prepared in water) both equilibrated to 50
◦C.
The suspension was mixed and dispensed as 20mL portions
into each of ten Petri plates (15 × 100mm). The medium
(TSHA) was allowed to solidify and plates were incubated
overnight at 37
◦C before use. Overnight cultures of S. aureus
strains ATCC 33753 and Newman and S. epidermidis strain
ATCC12228weredilutedwithTSB,mixedinequalportions,
and plated onto TSHA plates to yield 30-300 colonies per
plate. Plates were incubated overnight (15–18 hours) at 37
◦C
priortoﬂoodingeachplatewith2Maceticacidtoprecipitate
undigested HA conjugated to BSA.
3. Results
3.1.HyaluronidaseActivityofS.Aureus. Hyaluronidaseactiv-
ity was detected for 93% (40 of 43) of S. aureus strains
(Table 1) examined while none of the remaining species
exhibited hyaluronidase activity (data not shown) including
S. hyicus subsp. hyicus ATCC 11249T (Figure 3(a)); the only
species other than S. aureus reported to have hyaluronidase
activity [13, 19, 25].International Journal of Microbiology 5
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Figure 3: Panel (a) Hyaluronidase activity from spent media
isolated from S. hyicus subsp. hyicus ATCC 11249T (1), S.
schleiferi subsp. coagulans ATCC 49545T (2), and bovine testicular
hyaluronidase (3). Panel (b) Southern analysis of ClaI-digested
chromosomal DNA isolated from S. hyicus subsp. hyicus ATCC
11249T (1),S.schleiferisubsp.coagulansATCC49545T (2),S.aureus
SH1000 (3), and Sanger-252 (4). M: marker (kilobases).
The hyaluronidase-producing strains of S. aureus exam-
ined included three ATCC strains, eight sequenced strains,
and two isolates of pulse-ﬁeld type, USA-300 (Miss and
LAC) (Table 1). The remaining strains examined included
17 vaginal toxic shock syndrome- (TSS-) producing clinical
isolates and 15 clinical strains (Table 1). The identity of
the three hyaluronidase nonproducing strains as S. aureus
(NCH 241, 242, and 250) was determined by Gram stain,
growth on mannitol salt agar and catalase, coagulase, and
DNAse activities (data not shown). Their identities were
conﬁrmedusingtheVitek2Compact(bioM´ erieux,Durham,
N.C.) automated system and the ID-GP identiﬁcation cards
(bioM´ erieux). Strain NCH 242 was identiﬁed as S. aureus
with low discrimination between it and S. intermedius but
was positive with the Voges-Proskauer test. Staphylococcus
intermedius,l i k eS. aureus, produces coagulase and DNAse
as well as utilize mannitol [13]. However, unlike S. aureus,
S. intermedius is unable to ferment glucose to acetylmethyl-
carbinol (acetoin), and thus, is negative with the Voges-
Proskauer test [13].
3.2. Southern Analysis. Chromosomal DNA was isolated
from all strains and digested with the restriction endonu-
clease, ClaI. This enzyme was chosen because it does
not cut within the open reading frame of any of the
hyaluronidase genes found in the 14 sequenced S. aureus
genomicdatabases(datanotshown).DigestedDNAresolved
by gel electrophoresis was analyzed by Southern analysis
using a probe generated from the sequence of one of the
hyaluronidase genes (hysA1) found in S. aureus UAMS-1 and
from the corresponding gene found in S. aureus RN6390.
Under high stringency conditions (65
◦C and low salt) both
probes hybridized to the same ClaI fragment containing a
hyaluronidase gene with equal intensities (data not shown).
Staphylococcus aureus SH1000 (8325 lineage) and Sanger-
252 were included in all Southern analysis as representative
strains containing one and two hysA genes, respectively,
as demonstrated by sequence analysis of their respective
databases and independent cloning and sequencing of all
three genes (data not shown).
Approximately half (53.5%) of the 43 S. aureus strains
examined exhibited two hybridizing bands and two strains
(NTH 79 and 81) exhibited three hybridizing bands (Table 1
and Figures 1 and 2). These data suggest that these
strains contain multiple copies of the hyaluronidase gene.
The existence of smaller ClaI hybridizing fragments was
noted for two strains, NTH 75 and NTH 78, and so
the potential for restriction fragment length polymorphism
exists. None of the remaining 19 species of Staphylococcus
exhibited a hybridizing band for hysA (Figures 1 and 2)
including the type strain for S. hyicus subsp. hyicus ATCC
11249T(Figure 3(b)).
3.3. Detecting Hyaluronidase-Producing Strains on TSHA.
Three strains of Staphylococcus, S. aureus strain ATCC 33753,
S. aureus strain Newman, and S. epidermidis strain ATCC
12228 exhibiting a large (13.2 ± 1.3), small (5.8 ± 2.5), and
no zone of activity on HA plates, respectively, were mixed
and plated onto TSHA to determine whether or not TSHA
could be used to discern Staphylococcus strains expressing
hyaluronidase at diﬀerent levels. All three strains could easily
be discerned, as evident by the diﬀerences in zone sizes after
overnight incubation at 37
◦C( Figure 4).
4. Discussion
Previousstudies[23,24]examinedalargenumberofstaphy-
lococcal strains for the presence of hyaluronidase activity.
While species identity was not determined in most cases, the
strains were characterized as either positive or negative for
coagulase or DNAse activities, characteristics typically used
to distinguish S. aureus from other staphylococcal species
[13]. In these studies [23, 24] the vast majority (93%) of
strains that exhibited coagulase and DNAse activities also
exhibited hyaluronidase activity.6 International Journal of Microbiology
(a) (b)
(c) (d)
Figure 4: Hyaluronidase detection on tryptic soy agar supplemented with hyaluronic acid. S. aureus ATCC 33753 (a), S. aureus Newman
(b), S. epidermidis ATCC 12228 (c), and a mixture of all three (d). Colonies of S. aureus Newman did not adhere to the agar surface when
acetic acid was removed from the plates for photographic documentation.
In the present study, we have examined the type strain
for 20 diﬀerent species of Staphylococcus for their ability
to degrade hyaluronic acid and of these, only S. aureus
strains exhibited hyaluronidase activity. In addition, over
half of the S. aureus strains examined exhibited two or
more genes for hyaluronidase. While the number of genes
per strain will need to be conﬁrmed, we know from the
genomic databases of S. aureus Sanger-252 and RF-122 [11,
28, 29] and the proteomic analysis of S. aureus UAMS-1
[10] that these strains contain two genes for hyaluronidase.
Whether or not the presence of two or more hyaluronidase
genes aﬀords some metabolic or pathogenic advantage is
currently under investigation. However, it must be pointed
out that an increase in the number of potential genes for
any one strain did not necessarily result in an increase in
hyaluronidase activity as determined with the hyaluronidase
assay used in this study. In addition, not all S. aureus
strains produced hyaluronidase although Southern analysis
indicatedthepresenceofatleastonegeneineachofthethree
strains that failed to exhibit hyaluronidase activity. It is also
interesting that two of these hyaluronidase nonproducing
strains appear to have two hysA genes. While at present
we have no supporting data, this might suggest that either
these strains carry two copies of the same defective gene or
an important regulator of hysA expression is nonfunctional.
Nevertheless, given the limited number of S. aureus strains
examined in our study and the fact that some strains
did not produce hyaluronidase would suggest that the
lack of hyaluronidase by S. aureus is more prevalent than
originally thought and that the enzyme may not be a
contributing factor in virulence. Whether this is true or
not will require further investigation particularly given that
hyaluronidase has been implicated as a virulence factor
in the mouse abscess model [9] and that the primarily
virulence gene regulator, SarA, controls its expression [9,
10].
We are also intrigued that under our assay conditions as
well as the Southern analysis that S. hyicus subsp. hyicus,a
strain known to cause infectious exudative epidermititis in
swine and reported to have hyaluronidase activity [13, 19,
25], exhibited no activity nor did it have a hybridizing band
corresponding to the hysA gene from S. aureus.C u r r e n t l y ,
it is unclear as to why this discrepancy exists other than
previous investigations [13, 19, 25] relied on the appearance
of nonmucoid colonies of Streptococcus equi, which possesses
a hyaluronic acid-containing capsule [30, 31] on blood agar
when Streptococcus equi was plated as a lawn and Staphy-
lococcus species, including S. hyicus were “spot” inoculatedInternational Journal of Microbiology 7
onto the lawn [32]. This would suggest, perhaps, that some
factor other than hyaluronidase contributes to the formation
of nonmucoid Streptococcus equi colonies.
Lastly, while the method employed in this study clearly
distinguished hyaluronidase-producing colonies from those
that did not, more than likely the detection of hyaluronidase
activity as a diagnostic test for the presumptive identiﬁcation
of S. aureus would not be feasible given the fact that not all S.
aureus strains possess hyaluronidase activity. However, using
methodsthatdetectthepresenceorabsenceofthegenecould
possibly be used as 100% of the S. aureus strains examined in
this study contained at least one gene for hysA.
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